LLY vs. LRCX
Compare and contrast key facts about Eli Lilly and Company (LLY) and Lam Research Corporation (LRCX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LLY or LRCX.
Correlation
The correlation between LLY and LRCX is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LLY vs. LRCX - Performance Comparison
Key characteristics
LLY:
-0.06
LRCX:
-0.33
LLY:
0.21
LRCX:
-0.18
LLY:
1.03
LRCX:
0.98
LLY:
-0.05
LRCX:
-0.38
LLY:
-0.11
LRCX:
-0.64
LLY:
12.37%
LRCX:
28.31%
LLY:
37.94%
LRCX:
51.74%
LLY:
-68.27%
LRCX:
-87.91%
LLY:
-21.46%
LRCX:
-32.95%
Fundamentals
LLY:
$737.66B
LRCX:
$95.32B
LLY:
$12.27
LRCX:
$3.59
LLY:
66.95
LRCX:
20.76
LLY:
1.33
LRCX:
1.10
LLY:
15.05
LRCX:
5.56
LLY:
46.91
LRCX:
10.02
LLY:
$49.00B
LRCX:
$17.14B
LLY:
$40.03B
LRCX:
$8.24B
LLY:
$16.67B
LRCX:
$5.83B
Returns By Period
In the year-to-date period, LLY achieves a -2.49% return, which is significantly lower than LRCX's 4.01% return. Both investments have delivered pretty close results over the past 10 years, with LLY having a 28.61% annualized return and LRCX not far behind at 27.29%.
LLY
-2.49%
3.47%
-5.45%
-2.41%
39.23%
28.61%
LRCX
4.01%
24.32%
-4.86%
-17.08%
24.60%
27.29%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LLY vs. LRCX — Risk-Adjusted Performance Rank
LLY
LRCX
LLY vs. LRCX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and Lam Research Corporation (LRCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LLY vs. LRCX - Dividend Comparison
LLY's dividend yield for the trailing twelve months is around 0.72%, less than LRCX's 1.19% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 0.72% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% | 2.84% |
LRCX Lam Research Corporation | 1.19% | 1.19% | 0.95% | 1.53% | 0.78% | 1.04% | 1.54% | 2.79% | 1.01% | 1.28% | 1.36% | 0.68% |
Drawdowns
LLY vs. LRCX - Drawdown Comparison
The maximum LLY drawdown since its inception was -68.27%, smaller than the maximum LRCX drawdown of -87.91%. Use the drawdown chart below to compare losses from any high point for LLY and LRCX. For additional features, visit the drawdowns tool.
Volatility
LLY vs. LRCX - Volatility Comparison
Eli Lilly and Company (LLY) has a higher volatility of 22.38% compared to Lam Research Corporation (LRCX) at 21.15%. This indicates that LLY's price experiences larger fluctuations and is considered to be riskier than LRCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
LLY vs. LRCX - Financials Comparison
This section allows you to compare key financial metrics between Eli Lilly and Company and Lam Research Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LLY vs. LRCX - Profitability Comparison
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
LRCX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Lam Research Corporation reported a gross profit of 2.31B and revenue of 4.72B. Therefore, the gross margin over that period was 49.0%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
LRCX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Lam Research Corporation reported an operating income of 1.56B and revenue of 4.72B, resulting in an operating margin of 33.1%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.
LRCX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Lam Research Corporation reported a net income of 1.33B and revenue of 4.72B, resulting in a net margin of 28.2%.